These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 22999240)

  • 21. Lipid lowering therapy for adults with diabetes.
    Jackowski L; Crockett J; Rowett D
    Aust Fam Physician; 2008; 37(1-2):39-41. PubMed ID: 18239751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The early effects of elevated glucose on endothelial function as a target in the treatment of type 2 diabetes.
    Triggle CR
    Timely Top Med Cardiovasc Dis; 2008 Feb; 12():E3. PubMed ID: 18392213
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacotherapy of diabetes mellitus: implications for the prevention and treatment of cardiovascular disease.
    Ragucci E; Zonszein J; Frishman WH
    Heart Dis; 2003; 5(1):18-33. PubMed ID: 12549986
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic approach to managing hyperglycemia for the nonendocrinologist.
    Deeg MA
    Am J Cardiol; 2005 Aug; 96(4A):37E-40E. PubMed ID: 16098842
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Endothelial dysfunction: its relationship with acute hyperglycaemia and hyperlipidemia.
    Lee IK; Kim HS; Bae JH
    Int J Clin Pract Suppl; 2002 Jul; (129):59-64. PubMed ID: 12166609
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Acute glucose fluctuations and chronic sustained hyperglycemia as risk factors for cardiovascular diseases in patients with type 2 diabetes.
    Colette C; Monnier L
    Horm Metab Res; 2007 Sep; 39(9):683-6. PubMed ID: 17846977
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diabetes and vascular disease.
    Deedwania P; Srikanth S
    Expert Rev Cardiovasc Ther; 2008 Jan; 6(1):127-38. PubMed ID: 18095912
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Manipulating the vascular biology of coronary atherosclerosis in diabetes: new opportunities.
    Orford JL; Kinlay S; Fernandes J; Behrendt D; Ganz P; Selwyn AP
    J Lab Clin Med; 2001 Feb; 137(2):82-92. PubMed ID: 11174464
    [No Abstract]   [Full Text] [Related]  

  • 29. Why does diabetes mellitus increase the risk of cardiovascular disease?
    Shahab A
    Acta Med Indones; 2006; 38(1):33-41. PubMed ID: 16479030
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Current antihyperglycemic treatment strategies for patients with type 2 diabetes mellitus.
    Blonde L
    Cleve Clin J Med; 2009 Dec; 76 Suppl 5():S4-11. PubMed ID: 19952303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Postprandial lipemia: an under-recognized atherogenic factor in patients with diabetes mellitus.
    Pastromas S; Terzi AB; Tousoulis D; Koulouris S
    Int J Cardiol; 2008 May; 126(1):3-12. PubMed ID: 17689745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postprandial dysmetabolism: the missing link between diabetes and cardiovascular events?
    Bell DS; O'Keefe JH; Jellinger P
    Endocr Pract; 2008; 14(1):112-24. PubMed ID: 18238751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Using insulin as a drug rather than as a replacement hormone during acute illness: a new paradigm.
    Pantaleo A; Zonszein J
    Heart Dis; 2003; 5(5):323-33. PubMed ID: 14503930
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Treatment of type 2 diabetes].
    Daubresse JC
    Rev Med Brux; 2004 Feb; 25(1):22-8. PubMed ID: 15053151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Targeting post-prandial hyperglycemia.
    Menke J
    S D J Med; 2001 Oct; 54(10):399-400. PubMed ID: 11668889
    [No Abstract]   [Full Text] [Related]  

  • 36. Cardiovascular effects of acute hyperglycaemia: pathophysiological underpinnings.
    Ceriello A
    Diab Vasc Dis Res; 2008 Nov; 5(4):260-8. PubMed ID: 18958835
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Postprandial lipaemia, oxidative stress and endothelial function: a review.
    Wallace JP; Johnson B; Padilla J; Mather K
    Int J Clin Pract; 2010 Feb; 64(3):389-403. PubMed ID: 20456177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hyperlipidemia and cardiovascular risk factors in patients with type 2 diabetes.
    Goldberg RB
    Am J Manag Care; 2000 Aug; 6(13 Suppl):S682-91; discussion S692-6. PubMed ID: 11183421
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New drugs for reducing cardiovascular risk in women.
    Thacker HL; Saadi H
    Cleve Clin J Med; 1997 Oct; 64(9):493-502. PubMed ID: 9339048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Postprandial hyperglycemia. Postprandial blood glucose fluctuations, cardiovascular disease and late diabetic complications].
    Madsbad S; Brock B; Schmitz O
    Ugeskr Laeger; 2003 Aug; 165(33):3149-53. PubMed ID: 12968409
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.